News

New member | IRICE

Jeanne Chamousset-Roman is Consultant in Regulatory Affairs and Quality Management in MEDICAL DEVICES supporting companies for various procedures: Regulatory... View Article

Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate

Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is... View Article

Valneva Reports FY 2020 Cash of Over €200 Million

FY 2020 cash and cash equivalents of €204.4 million, exceeding guidance of between €180 million and €200 million. FY 2020... View Article

New member | MAD-UP

MAD-UP specializes in the development of technological solutions for the health care of musculoskeletal disorders. Its intelligent dynamic compression solution... View Article

GlioCure announces that it has been granted patent protection of its drug candidate GC01 in India

GlioCure SAS, a biotechnology company specialised in neuro-oncology, announced that it has been granted an Indian patent for its drug... View Article

OSE Immunotherapeutics Announces Enrolment of First Patient with Ulcerative Colitis in Phase 2 Trial Testing Anti-IL-7 Receptor Antagonist OSE-127/S95011

OSE Immunotherapeutics today announced enrolment of the first patient in its Phase 2 clinical trial evaluating the benefits of anti-IL-7... View Article

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine

• CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in preclinical and human ex... View Article